European Diabetes Leadership Forum Participation Report
date : 4/26/2012
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
Exhibition date:2012-04-26
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”